• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡罗昔康。对其药理学和治疗效果的重新评估。

Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

作者信息

Brogden R N, Heel R C, Speight T M, Avery G S

出版信息

Drugs. 1984 Oct;28(4):292-323. doi: 10.2165/00003495-198428040-00002.

DOI:10.2165/00003495-198428040-00002
PMID:6386426
Abstract

Piroxicam is a chemically different non-steroidal anti-inflammatory drug with a long half-life which enables it to be administered once daily. This member of the oxicam series of compounds is now well established in the treatment of rheumatoid arthritis and osteoarthritis and has been shown to be a suitable alternative to aspirin, indomethacin, naproxen, ibuprofen, ketoprofen, sulindac, phenylbutazone and diclofenac in the treatment of rheumatic diseases. Open trials in many thousands of patients in hospital clinics and in general practice have demonstrated its analgesic and anti-inflammatory efficacy in a wide cross-section of patients with rheumatic diseases, when administered once daily either at night or in the morning, and recent studies have demonstrated its usefulness in musculoskeletal disorders, dysmenorrhoea and postoperative pain. Such studies have also demonstrated the generally good tolerability of piroxicam 20mg daily. As with other non-steroidal anti-inflammatory drugs, gastrointestinal complaints are the most frequently reported side effects. The frequency and severity of these effects are dose related. Thus, piroxicam is now well established in the treatment of rheumatic diseases and offers an alternative to other analgesics in various pain states.

摘要

吡罗昔康是一种化学结构不同的非甾体抗炎药,半衰期长,可每日给药一次。这种氧杂蒽类化合物现已在类风湿性关节炎和骨关节炎的治疗中得到广泛应用,并且已证明在治疗风湿性疾病方面,它是阿司匹林、吲哚美辛、萘普生、布洛芬、酮洛芬、舒林酸、保泰松和双氯芬酸的合适替代品。在医院诊所和普通医疗中对数千名患者进行的开放试验表明,当每天晚上或早上给药一次时,它对广泛的风湿性疾病患者具有镇痛和抗炎功效,并且最近的研究表明它在肌肉骨骼疾病、痛经和术后疼痛方面也有用处。这些研究还表明,每日服用20mg吡罗昔康通常耐受性良好。与其他非甾体抗炎药一样,胃肠道不适是最常报告的副作用。这些副作用的频率和严重程度与剂量有关。因此,吡罗昔康现已在风湿性疾病的治疗中得到广泛应用,并为各种疼痛状态下的其他镇痛药提供了一种替代选择。

相似文献

1
Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.吡罗昔康。对其药理学和治疗效果的重新评估。
Drugs. 1984 Oct;28(4):292-323. doi: 10.2165/00003495-198428040-00002.
2
Pharmacology, clinical efficacy, and adverse effects of piroxicam, a new nonsteroidal anti-inflammatory agent.新型非甾体抗炎药吡罗昔康的药理学、临床疗效及不良反应
Pharmacotherapy. 1982 Mar-Apr;2(2):80-90. doi: 10.1002/j.1875-9114.1982.tb03178.x.
3
Piroxicam: a review of its pharmacological properties and therapeutic efficacy.吡罗昔康:其药理特性与治疗效果综述
Drugs. 1981 Sep;22(3):165-87. doi: 10.2165/00003495-198122030-00001.
4
Piroxicam--a literature review of new results from laboratory and clinical studies.
Eur J Rheumatol Inflamm. 1983;6(1):3-23.
5
Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.噻洛芬酸。对其在风湿性疾病和疼痛状态下的药理特性及治疗效果的综述。
Drugs. 1985 Mar;29(3):208-35. doi: 10.2165/00003495-198529030-00002.
6
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.双氯芬酸钠:其药理特性及在风湿性疾病和各种原因引起的疼痛中的治疗应用综述
Drugs. 1980 Jul;20(1):24-48. doi: 10.2165/00003495-198020010-00002.
7
Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.非诺洛芬:其药理特性及在风湿性疾病中治疗效果的综述
Drugs. 1977 Apr;13(4):241-65. doi: 10.2165/00003495-197713040-00001.
8
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展:对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.
9
Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.替诺昔康。对其药效学、药代动力学特性及治疗效果的初步综述。
Drugs. 1987 Sep;34(3):289-310. doi: 10.2165/00003495-198734030-00001.
10
Isoxicam.异恶酰草胺
Clin Rheum Dis. 1984 Aug;10(2):385-99.

引用本文的文献

1
A Life-threatening Cup of Tea: A Case Report and Literature Review.一杯危及生命的茶:病例报告与文献综述
J Community Hosp Intern Med Perspect. 2024 May 7;14(3):51-54. doi: 10.55729/2000-9666.1334. eCollection 2024.
2
Rapid Sublingual Delivery of Piroxicam from Electrospun Cyclodextrin Inclusion Complex Nanofibers.吡罗昔康从电纺环糊精包合物纳米纤维中的快速舌下给药
ACS Omega. 2022 Sep 19;7(39):35083-35091. doi: 10.1021/acsomega.2c03987. eCollection 2022 Oct 4.
3
Nanohydrogels Based on Self-Assembly of Cationic Pullulan and Anionic Dextran Derivatives for Efficient Delivery of Piroxicam.

本文引用的文献

1
Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.尿液中酮洛芬、萘普生和丙磺舒原形药物的排泄量可忽略不计。
J Pharm Sci. 1980 Nov;69(11):1254-7. doi: 10.1002/jps.2600691105.
2
A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium.一项关于阿司匹林对口服及静脉注射双氯芬酸钠药代动力学影响的研究。
Eur J Clin Pharmacol. 1980 Nov;18(5):415-8. doi: 10.1007/BF00636795.
3
Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.
基于阳离子普鲁兰多糖和阴离子葡聚糖衍生物自组装的纳米水凝胶用于吡罗昔康的高效递送
Pharmaceutics. 2019 Nov 21;11(12):622. doi: 10.3390/pharmaceutics11120622.
4
Photosensitizers Used in the Photodynamic Therapy of Rheumatoid Arthritis.光动力疗法治疗类风湿关节炎中使用的光敏剂。
Int J Mol Sci. 2019 Jul 7;20(13):3339. doi: 10.3390/ijms20133339.
5
Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases.外用0.8%吡罗昔康和50+防晒霜治疗器官移植受者的多发性光化性角化病及癌化区域:10例系列报道
Case Rep Dermatol. 2017 Oct 20;9(3):211-216. doi: 10.1159/000481770. eCollection 2017 Sep-Dec.
6
Non-steroidal anti-inflammatory drugs activate NADPH oxidase in adipocytes and raise the H2O2 pool to prevent cAMP-stimulated protein kinase a activation and inhibit lipolysis.非甾体抗炎药激活脂肪细胞中的 NADPH 氧化酶,并增加 H2O2 池,以防止 cAMP 刺激的蛋白激酶 A 激活并抑制脂肪分解。
BMC Biochem. 2013 May 30;14:13. doi: 10.1186/1471-2091-14-13.
7
Piroxicam-β-cyclodextrin: a GI safer piroxicam.吡罗昔康-β-环糊精:一种胃肠道安全性更高的吡罗昔康。
Curr Med Chem. 2013;20(19):2415-37. doi: 10.2174/09298673113209990115.
8
Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam.CYP2C9*1/*13 对美洛昔康药代动力学和药效学的影响。
Br J Clin Pharmacol. 2011 Apr;71(4):550-5. doi: 10.1111/j.1365-2125.2010.03853.x.
9
A Review of Fatalities Reported as Associated with NSAID Treatment in Ontario.安大略省与非甾体抗炎药治疗相关的死亡报告综述。
Can Fam Physician. 1986 Sep;32:1931-4.
10
Stability studies of microparticulate system with piroxicam as model drug.以吡罗昔康为模型药物的微粒系统稳定性研究。
AAPS PharmSciTech. 2009;10(3):872-80. doi: 10.1208/s12249-009-9280-8. Epub 2009 Jul 1.
酮洛芬单次口服、肌内注射和直肠给药后以及重复口服给药后的药代动力学。
Eur J Clin Pharmacol. 1980 Nov;18(5):407-14. doi: 10.1007/BF00636794.
4
Comparative study with piroxicam and ibuprofen versus placebo in the supportive treatment of minor sports injuries.吡罗昔康和布洛芬与安慰剂在轻度运动损伤支持性治疗中的对比研究。
J Int Med Res. 1980;8(4):265-9. doi: 10.1177/030006058000800404.
5
The topical anti-inflammatory effects of piroxicam in rodents.吡罗昔康在啮齿动物中的局部抗炎作用。
Agents Actions. 1980 Jun;10(3):246-51. doi: 10.1007/BF02025943.
6
Analysis of piroxicam in plasma by high-performance liquid chromatography.采用高效液相色谱法分析血浆中的吡罗昔康。
J Chromatogr. 1980 Jul 11;183(1):104-8. doi: 10.1016/s0378-4347(00)81406-1.
7
The analgetic properties of piroxicam in animals and correlation with experimentally determined plasma levels.吡罗昔康在动物中的镇痛特性及其与实验测定的血浆水平的相关性。
Agents Actions. 1980 Apr;10(1 Pt 2):31-7. doi: 10.1007/BF02024176.
8
Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study.吡罗昔康,一种在细胞培养中前列腺素生成的强效抑制剂。构效关系研究。
Prostaglandins. 1980 Jan;19(1):51-9. doi: 10.1016/0090-6980(80)90153-7.
9
Clinical response and serum prostaglandin levels in aspirin idiosyncrasy. Effect of aspirin and a new nonsteroidal anti-inflammatory agent.
Chest. 1981 Dec;80(6):676-81. doi: 10.1378/chest.80.6.676.
10
An analysis of piroxicam in rodent models of arthritis.吡罗昔康在关节炎啮齿动物模型中的分析。
Agents Actions. 1982 Jul;12(3):308-12. doi: 10.1007/BF01965395.